FTC Case Against J&J’s Remicade Inches Toward Litigation as FTC Considers Consumer Protection Count

Published on Sep 12, 2023

The FTC’s four-year investigation of Johnson & Johnson’s (JNJ) allegedly illegal conduct in defending the market share of its blockbuster drug Remicade is inching toward litigation, according to sources familiar with the matter. The investigation is broader than has been publicly disclosed, encompassing consumer protection concerns as well as the previously known focus on the […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

© 2024 the Capitol Forum